NinePointTwo Capital
- SEC CIK
- 0001824516
- Latest filing
- Feb 14, 2024
RCUS holding history
Arcus Biosciences, Inc. in every 13F filed by NinePointTwo Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCUS overviewAll 13F holders of RCUSFull Q4 2023 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −15,916−100.0% | Sold out | Holders |
| Q1 2023 | 15,916 | $290.0K | 0.1% | +15,916 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −8,732−100.0% | Sold out | Holders |
| Q3 2022 | 8,732 | $228.0K | 0.1% | −8,704−49.9% | Reduced | Holders |
| Q2 2022 | 17,436 | $441.0K | 0.2% | +17,436 | New | Holders |